Article

Development of a novel, pan-variant aerosol intervention for COVID-19

2021-09-14

Abstract excerpt

To develop a universal strategy to block SARS-CoV-2 cellular entry and infection represents a central aim for effective COVID-19 therapy. The growing impact of emerging variants of concern increases the urgency for development of effective interventions. Since ACE2 is the critical SARS-CoV-2 receptor and all tested variants bind to ACE2, some even at much increased affinity (see accompanying paper), we hypothesize...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3764c9a3-0848-50b8-9171-dd2a381cf554
DOI: 10.1101/2021.09.14.459961

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of a novel, pan-variant aerosol intervention for COVID-19DOI 10.1101/2021.09.14.459961Read

Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivoSemantic proximity Read

Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo.Semantic proximity Read

Intranasal Administration of ACIS KEPTIDE™ Prevents SARS-CoV2-Induced Acute Toxicity in K18-hACE2 Humanized Mouse Model of COVID-19: A Mechanistic Insight for the Prophylactic Role of KEPTIDE™ in COVID-19Semantic proximity Read

A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in miceSemantic proximity Read

Potential COVID‐19 therapeutic approaches targeting angiotensin‐converting enzyme 2; An updated reviewSemantic proximity Read

Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory diseaseSemantic proximity Read

An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoVSemantic proximity Read

A novel soluble ACE2 protein totally protects from lethal disease caused by SARS-CoV-2 infectionSemantic proximity Read

A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application.Semantic proximity Read

Evaluation of K18- <i>hACE2</i> mice as a model of SARS-CoV-2 infectionSemantic proximity Read

Broadly effective ACE2 decoy proteins protect mice from lethal SARS-CoV-2 infectionSemantic proximity Read

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variantsSemantic proximity Read